Occupation or Discipline
FDA Establishes AI Council to Oversee Ongoing and Future AI Projects
FDA, AI Council, Digital Health Advisory Committee, Artificial Intelligence, Machine Learning, Regulatory Guidance
Genentech Announces 93 Layoffs in California Amid Restructuring Efforts
Genentech layoffs, California job cuts, biotech industry, cancer immunology research, restructuring efforts
Bayer Announces 150 Job Cuts in Basel, Switzerland, Amid Global Restructuring
Bayer layoffs, Basel, Switzerland, consumer health hub, job cuts, restructuring
Biopharma Layoff Tracker 2024: Industry Continues to Downsize Amid Financial Pressures
Biopharma layoffs, job cuts, restructuring, financial pressures, industry trends
Navigating Challenges and Opportunities in the 2024 Life Sciences Industry Outlook
Life Sciences Industry, 2024 Outlook, Biotechnology, Medical Devices, Artificial Intelligence, Drug Pricing, Regulatory Changes, Supply Chain Security, Talent Shortage
Embracing Agility: Critical for the Role of QARA Professional
QARA Professional, Agility, Quality Assurance, Regulatory Affairs, Market Access, Innovative Therapeutic Solutions, AI, Technology, Regulatory Strategy, Leadership, Communication, Diversity, Inclusion.
FDA’s Rejection of Lykos’ MDMA-Assisted Therapy for PTSD: A Setback but Not a Roadblock for Psychedelic Research
MDMA, PTSD, Lykos Therapeutics, FDA rejection, psychedelic therapy, clinical trials, ethical violations, scientific integrity.
Evotec Announces 400 Job Cuts Amid Market Challenges
Evotec, job cuts, market challenges, restructuring, drug discovery, contract development, manufacturing
Biopharma Layoff Tracker 2024: FibroGen, Ajinomoto, AN2 Therapeutics and More Cut Staff
Biopharma layoffs, FibroGen, Ajinomoto, AN2 Therapeutics, pharmaceutical industry, job cuts, restructuring
Precigen Restructures, Reduces CAR-T Efforts Amid Job Cuts
Precigen, CAR-T, restructuring, job cuts, UltraCAR-T, gene therapy, AdenoVerse, PRGN-2012